title: Follow up of three cases after adjuvant treatment of high risk gastrointestinal stromal tumors with Imatinib.
authors.forename: T
authors.initials: T
authors.lastname: Armbrust
authors.forename: M
authors.initials: M
authors.lastname: Sobotta
authors.forename: G
authors.initials: G
authors.lastname: Ramadori
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D017024:Chemotherapy, Adjuvant; D005500:Follow-Up Studies; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate